Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Eli Lilly reported these results in mid-2025, and the retatrutide availability timeline now points toward potential FDA approval no earlier than 2027, as additional phase 3 trials continue
Retatrutide is a once-weekly injectable medication currently in clinical trials
Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus
Understanding the mechanisms by which bacteria induce ferroptosis can provide new therapeutic targets and strategies for combating infectious diseases
Prescription GLP-1 medications cost $245349 per month through manufacturer programs as of 2026, or more without them
Allergy warning: Contains soy
